ELIQUIS SPRINKLE

Product NDC
0003-0898
Requested package NDC
0003-0898-28
11-digit product format
000030898
Labeler code
0003
Product ID
0003-0898_188961fc-00f8-4848-a611-c3c85764baf8
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
apixaban
Dosage form
CAPSULE
Route
ORAL
Labeler
E.R. Squibb & Sons, L.L.C.
Application
NDA220073
Marketing category
NDA
Marketing start
2025-09-15
Substance
APIXABAN
Active strength
.15 mg/1
Pharmacologic classes
Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N220073-001ELIQUIS SPRINKLEAPIXABAN0.15MGFOR SUSPENSION / ORALRLD, RS2025-04-17

Orange Book patents#

Current patent rows page 1 of 1 · 4 matching rows.

Application-product, Patent, Expiration table
Application-productPatentExpirationUse codeCoverage / statusSubmission date
N220073-00169672082026-11-21U-4180Drug substance, Drug product2025-05-16
N220073-0016967208*PED2027-05-21Pediatric extension
N220073-001118965862040-11-22U-4180Drug product2025-05-16
N220073-00111896586*PED2041-05-22Pediatric extension

Orange Book exclusivity#

Current exclusivity rows page 1 of 1 · 2 matching rows.

Application-product, Exclusivity code, Expiration table
Application-productExclusivity codeExpiration
N220073-001NP2028-04-17
N220073-001PED2028-10-17

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10N220073-001ELIQUIS SPRINKLE0.15MGFOR SUSPENSION / ORALRLD, RS2025-04-17d4dbc9d85df4…
2026-10-15 13:18:302026-09N220073-001ELIQUIS SPRINKLE0.15MGFOR SUSPENSION / ORALRLD, RS2025-04-17c2088c7a36db…
2026-09-14 22:38:342026-08N220073-001ELIQUIS SPRINKLE0.15MGFOR SUSPENSION / ORALRLD, RS2025-04-1784e616aacf4f…
2026-08-18 06:07:402026-07N220073-001ELIQUIS SPRINKLE0.15MGFOR SUSPENSION / ORALRLD, RS2025-04-17caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N220073-001ELIQUIS SPRINKLE0.15MGFOR SUSPENSION / ORALRLD, RS2025-04-17011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N220073-001ELIQUIS SPRINKLE0.15MGFOR SUSPENSION / ORALRLD, RS2025-04-1731067a03dcf5…
2025-08-23 18:47 UTC2025-08N220073-001ELIQUIS SPRINKLE0.15MGFOR SUSPENSION / ORALRLD, RS2025-04-176a471c1ec25d…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N220073-001ELIQUIS SPRINKLE0.15MGFOR SUSPENSION / ORALRLD, RS2025-04-17a50c72e98297…

Observed Orange Book patent history#

Captured, Edition, Application-product table
CapturedEditionApplication-productPatentExpirationUse codeCoverage / statusSubmission dateSource SHA-256
2026-11-14 07:37:172026-10N220073-00169672082026-11-21U-4180Drug substance, Drug product2025-05-16d4dbc9d85df4…
2026-11-14 07:37:172026-10N220073-0016967208*PED2027-05-21Pediatric extensiond4dbc9d85df4…
2026-11-14 07:37:172026-10N220073-001118965862040-11-22U-4180Drug product2025-05-16d4dbc9d85df4…
2026-11-14 07:37:172026-10N220073-00111896586*PED2041-05-22Pediatric extensiond4dbc9d85df4…
2026-10-15 13:18:302026-09N220073-00169672082026-11-21U-4180Drug substance, Drug product2025-05-16c2088c7a36db…
2026-10-15 13:18:302026-09N220073-0016967208*PED2027-05-21Pediatric extensionc2088c7a36db…
2026-10-15 13:18:302026-09N220073-001118965862040-11-22U-4180Drug product2025-05-16c2088c7a36db…
2026-10-15 13:18:302026-09N220073-00111896586*PED2041-05-22Pediatric extensionc2088c7a36db…
2026-09-14 22:38:342026-08N220073-00169672082026-11-21U-4180Drug substance, Drug product2025-05-1684e616aacf4f…
2026-09-14 22:38:342026-08N220073-0016967208*PED2027-05-21Pediatric extension84e616aacf4f…
2026-09-14 22:38:342026-08N220073-001118965862040-11-22U-4180Drug product2025-05-1684e616aacf4f…
2026-09-14 22:38:342026-08N220073-00111896586*PED2041-05-22Pediatric extension84e616aacf4f…
2026-08-18 06:07:402026-07N220073-00169672082026-11-21U-4180Drug substance, Drug product2025-05-16caaa826d4ba7…
2026-08-18 06:07:402026-07N220073-0016967208*PED2027-05-21Pediatric extensioncaaa826d4ba7…
2026-08-18 06:07:402026-07N220073-001118965862040-11-22U-4180Drug product2025-05-16caaa826d4ba7…
2026-08-18 06:07:402026-07N220073-00111896586*PED2041-05-22Pediatric extensioncaaa826d4ba7…
2026-02-19 14:30 UTC2026-02N220073-00169672082026-11-21U-4180Drug substance, Drug product2025-05-16011fe1cb6892…
2026-02-19 14:30 UTC2026-02N220073-0016967208*PED2027-05-21Pediatric extension011fe1cb6892…
2026-02-19 14:30 UTC2026-02N220073-001118965862040-11-22U-4180Drug product2025-05-16011fe1cb6892…
2026-02-19 14:30 UTC2026-02N220073-00111896586*PED2041-05-22Pediatric extension011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N220073-00169672082026-11-21U-4180Drug substance, Drug product2025-05-1631067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N220073-0016967208*PED2027-05-21Pediatric extension31067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N220073-001118965862040-11-22U-4180Drug product2025-05-1631067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N220073-00111896586*PED2041-05-22Pediatric extension31067a03dcf5…
2025-08-23 18:47 UTC2025-08N220073-00169672082026-11-21U-4180Drug substance, Drug product2025-05-166a471c1ec25d…
2025-08-23 18:47 UTC2025-08N220073-0016967208*PED2027-05-21Pediatric extension6a471c1ec25d…
2025-08-23 18:47 UTC2025-08N220073-001118965862040-11-22U-4180Drug product2025-05-166a471c1ec25d…
2025-08-23 18:47 UTC2025-08N220073-00111896586*PED2041-05-22Pediatric extension6a471c1ec25d…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N220073-00169672082026-11-21U-4180Drug substance, Drug product2025-05-16a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N220073-0016967208*PED2027-05-21Pediatric extensiona50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N220073-001118965862040-11-22U-4180Drug product2025-05-16a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N220073-00111896586*PED2041-05-22Pediatric extensiona50c72e98297…

Observed Orange Book exclusivity history#

Captured, Edition, Application-product table
CapturedEditionApplication-productExclusivity codeExpirationSource SHA-256
2026-11-14 07:37:172026-10N220073-001NP2028-04-17d4dbc9d85df4…
2026-11-14 07:37:172026-10N220073-001PED2028-10-17d4dbc9d85df4…
2026-10-15 13:18:302026-09N220073-001NP2028-04-17c2088c7a36db…
2026-10-15 13:18:302026-09N220073-001PED2028-10-17c2088c7a36db…
2026-09-14 22:38:342026-08N220073-001NP2028-04-1784e616aacf4f…
2026-09-14 22:38:342026-08N220073-001PED2028-10-1784e616aacf4f…
2026-08-18 06:07:402026-07N220073-001NP2028-04-17caaa826d4ba7…
2026-08-18 06:07:402026-07N220073-001PED2028-10-17caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N220073-001NP2028-04-17011fe1cb6892…
2026-02-19 14:30 UTC2026-02N220073-001PED2028-10-17011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N220073-001NP2028-04-1731067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N220073-001PED2028-10-1731067a03dcf5…
2025-08-23 18:47 UTC2025-08N220073-001NP2028-04-176a471c1ec25d…
2025-08-23 18:47 UTC2025-08N220073-001PED2028-10-176a471c1ec25d…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N220073-001NP2028-04-17a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N220073-001PED2028-10-17a50c72e98297…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
ELIQUIS SPRINKLE
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
APIXABAN.15 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
3Z9Y7UWC1JInternal UNII lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
e9481622-7cc6-418a-acb6-c5450daae9b0Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
89fbc7dd-7e16-8a82-0070-9b9487bb8075Product name520260129

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0003-0898-28EA - Each0003-0898342f9840-5ec1-4989-9a50-b412fd21dc7f12025-10-14

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
apixabanACTIVE INGREDIENT3Z9Y7UWC1JELIQUIS (APIXABAN) TABLET, FILM COATED [E.R. SQUIBB & SONS, L.L.C.]7
apixabanACTIVE MOIETY3Z9Y7UWC1JELIQUIS (APIXABAN) TABLET, FILM COATED [E.R. SQUIBB & SONS, L.L.C.]7
anhydrous lactoseINACTIVE INGREDIENT3SY5LH9PMKELIQUIS (APIXABAN) TABLET, FILM COATED [E.R. SQUIBB & SONS, L.L.C.]7
cellulose, microcrystallineINACTIVE INGREDIENTOP1R32D61UELIQUIS (APIXABAN) TABLET, FILM COATED [E.R. SQUIBB & SONS, L.L.C.]7
croscarmellose sodiumINACTIVE INGREDIENTM28OL1HH48ELIQUIS (APIXABAN) TABLET, FILM COATED [E.R. SQUIBB & SONS, L.L.C.]7
ferric oxide redINACTIVE INGREDIENT1K09F3G675ELIQUIS (APIXABAN) TABLET, FILM COATED [E.R. SQUIBB & SONS, L.L.C.]7
ferric oxide yellowINACTIVE INGREDIENTEX438O2MRTELIQUIS (APIXABAN) TABLET, FILM COATED [E.R. SQUIBB & SONS, L.L.C.]7
hypromellosesINACTIVE INGREDIENT3NXW29V3WOELIQUIS (APIXABAN) TABLET, FILM COATED [E.R. SQUIBB & SONS, L.L.C.]7
lactose monohydrateINACTIVE INGREDIENTEWQ57Q8I5XELIQUIS (APIXABAN) TABLET, FILM COATED [E.R. SQUIBB & SONS, L.L.C.]7
magnesium stearateINACTIVE INGREDIENT70097M6I30ELIQUIS (APIXABAN) TABLET, FILM COATED [E.R. SQUIBB & SONS, L.L.C.]7
sodium lauryl sulfateINACTIVE INGREDIENT368GB5141JELIQUIS (APIXABAN) TABLET, FILM COATED [E.R. SQUIBB & SONS, L.L.C.]7
titanium dioxideINACTIVE INGREDIENT15FIX9V2JPELIQUIS (APIXABAN) TABLET, FILM COATED [E.R. SQUIBB & SONS, L.L.C.]7
triacetinINACTIVE INGREDIENTXHX3C3X673ELIQUIS (APIXABAN) TABLET, FILM COATED [E.R. SQUIBB & SONS, L.L.C.]7

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ELIQUISAPIXABANE.R. Squibb & Sons, L.L.C.e9481622-7cc6-418a-acb6-c5450daae9b02026-08-17Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 220073
application number: NDA220073
ndc (package): 0003-0898-28
ndc (product): 0003-0898
ndc11 (package): 00003089828

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1992428{74 (apixaban 5 MG Oral Tablet [Eliquis]) } Pack [Eliquis 30-Day Starter Pack]BPCKe9481622-7cc6-418a-acb6-c5450daae9b030
1992427{74 (apixaban 5 MG Oral Tablet) } PackGPCKe9481622-7cc6-418a-acb6-c5450daae9b030
1364435apixaban 2.5 MG Oral TabletPSNe9481622-7cc6-418a-acb6-c5450daae9b030
1992427apixaban 30-Day Starter PackPSNe9481622-7cc6-418a-acb6-c5450daae9b030
1364445apixaban 5 MG Oral TabletPSNe9481622-7cc6-418a-acb6-c5450daae9b030
1364441Eliquis 2.5 MG Oral TabletPSNe9481622-7cc6-418a-acb6-c5450daae9b030
1992428Eliquis 30-Day Starter PackPSNe9481622-7cc6-418a-acb6-c5450daae9b030
1364447Eliquis 5 MG Oral TabletPSNe9481622-7cc6-418a-acb6-c5450daae9b030
1364441apixaban 2.5 MG Oral Tablet [Eliquis]SBDe9481622-7cc6-418a-acb6-c5450daae9b030
1364447apixaban 5 MG Oral Tablet [Eliquis]SBDe9481622-7cc6-418a-acb6-c5450daae9b030
1364435apixaban 2.5 MG Oral TabletSCDe9481622-7cc6-418a-acb6-c5450daae9b030
1364445apixaban 5 MG Oral TabletSCDe9481622-7cc6-418a-acb6-c5450daae9b030
1992427apixaban 30-Day Starter PackSYe9481622-7cc6-418a-acb6-c5450daae9b030
1364441Eliquis 2.5 MG Oral TabletSYe9481622-7cc6-418a-acb6-c5450daae9b030
1992428Eliquis 30-Day Starter PackSYe9481622-7cc6-418a-acb6-c5450daae9b030
1364447Eliquis 5 MG Oral TabletSYe9481622-7cc6-418a-acb6-c5450daae9b030

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
0003-0898-280000308982828 CAPSULE in 1 BOTTLE (0003-0898-28) 28 capsule2025-09-15NoNoCurrent